NCT04616560 2026-04-13
Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma
National Cancer Institute (NCI)
Phase 2 Suspended
Clinical Trials
7 trialsNCT07283731 2026-04-06
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT03316573 2026-02-10
Pembrolizumab in Neoplasms or Lymphomas
Dana-Farber Cancer Institute
Phase 2 Suspended
NCT04824352 2024-05-14
AIEO
Peking University People's Hospital
Phase 2 Suspended
NCT02008019 2017-08-07
CHONRAD
Centre Leon Berard
Phase 2 Suspended
NCT00079950 2012-09-06
Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
Enzon Pharmaceuticals, Inc.
Phase 2 Suspended
NCT00003067 2009-02-09
Biological Therapy in Treating Patients With Primary or Advanced Glioma
National Cancer Institute (NCI)
Phase 2 Suspended